Lucy Greene Appointed NIDDK Executive Officer
Griffin P. Rodgers, M.D., director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), one of the National Institutes of Health (NIH), has appointed Lucy Greene associate director for management, NIDDK. In her new position, Dr. Greene will act as the executive officer for the Institute and advise the NIDDK director and other senior officials on all phases of administrative management involved in operating the Institute in support of biomedical research.
"Dr. Greene is an experienced administrator, manager and supervisor. Her extensive knowledge of federal management principles and practices, as well as her expertise in NIH policies and processes, makes her an ideal candidate and a great asset to the NIDDK," said Dr. Rodgers.
As associate director for management, Dr. Greene will be responsible for the Institute’s administrative functions, including leading the NIDDK Executive Office, which consists of six subordinate offices: the Administrative Management Branch, the Computer Technology Branch, the Office of Ethics, the Office of Financial Management, the Office of Management and Policy Analysis, and the Office of Workforce Development and Planning.
Dr. Greene has served as the deputy executive officer at the NIDDK since April 2006 and as the acting executive officer since April 2007. Prior to coming to NIDDK, Dr. Greene was deputy executive officer and associate director for administrative operations at the National Cancer Institute. She has 31 years of experience as an administrator in the Federal Government.
"I am honored and excited to be a part of the NIDDK team and to have the chance to contribute to NIDDK’s future successes," said Dr. Greene.
Dr. Greene earned a doctorate in planning and development studies from the University of Southern California, an M.A. degree in museum studies from George Washington University in Washington, D.C., and a B.A. cum laude in Latin from Gettysburg College in Gettysburg, P.A.
The NIDDK, a component of the NIH, conducts and supports research in diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition, and obesity; and kidney, urologic and hematologic diseases. Spanning the full spectrum of medicine and afflicting people of all ages and ethnic groups, these diseases encompass some of the most common, severe, and disabling conditions affecting Americans. For more information about NIDDK and its programs, see http://www.niddk.nih.gov.
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both common
and rare diseases. For more information about NIH and its programs,